Evidence map›Paper›PMID 42241232›Full record

ArticleMolecular human reproduction2026

Assessing efficacy of ADCY10 inhibitors in cervical mucus.

Justine Fischoeder, Jai G Marathe, Deborah J Anderson, Lonny R Levin, Jochen Buck, Carla Ritagliati

Abstract read
In one paragraph

Article in Molecular human reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Justine FischoederDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.
Jai G MaratheDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Deborah J AndersonDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Lonny R LevinDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-5204-6356
Jochen BuckDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-3568-5869
Carla RitagliatiDepartment of Pharmacology, Weill Cornell Medicine, New York, NY, USA.ORCID 0000-0002-0055-0681

Funding

Male Contraceptive InitiativeNIH HHS HD111549NIH HHS HD113015
6 · The paper itself

Abstract

Male fertility depends on sperm motility, which enables sperm to traverse the female reproductive tract to the site of fertilization. Soluble adenylyl cyclase (sAC) is a key regulator of sperm motility, defining it as a promising non-hormonal contraceptive target for women and men. To evaluate the efficacy of sAC inhibitors under conditions mimicking the female reproductive tract, we employed a capillary assay using cervical mucus isolated from humans or cows as well as methylcellulose, a viscoelastic liquid that simulates cervical mucus. Addition of a sAC inhibitor, either directly to semen, modeling an on-demand male contraceptive, or to the cervical mucus, approximating a female contraceptive, effectively blocked sperm migration. These studies provide proof-of-concept for the efficacy of sAC inhibitors under physiologically relevant conditions.

Indexed as

Adenylyl Cyclase InhibitorsAdenylyl CyclasesCervix MucusAnimalsCattleFemaleHumansMaleSpermatozoaSperm MotilityADCY10 protein, humanAdenylyl Cyclase InhibitorsAdenylyl Cyclasescapillary assaycervical mucuscontraceptivefemale reproductive tracthuman spermsACviscoelasticity

Identifiers

PMID42241232
PMCPMC13275317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.